Semaxa 3mg tablet

Semaxa 3mg is a starting dose tablet taken orally that contains Semaxa (oral semaglutide) which is GLP-1 receptor agonist used to acclimate the body to diabetes and weight management treatment.

Condition: Treats type 2 diabetes Semaxa 3mg tablet in pakistan mellitus and helps with gradual weight lossStarting dose: 3mg dose is considered as initiation dose meant to increase tolerance. Usually, doctors increase the dose to 7mg or 14mg later.Mechanism of action: It triggers insulin production, reduces Semaxa 3mg tablet price in pakistan glucagon, slows gastric emptying and decreases appetite.

Directions for use: It is taken orally once daily, preferably in the morning on an empty stomach with a little water. Side effects: Nausea, vomiting, diarrhea, constipation, and decreased appetite are among common side effects.

Semaglutide, available in products such as Rybelsus, is a GLP-1 receptor agonist used to manage type 2 diabetes mellitus and weight management along with proper nutrition and exercise. An initial, lower dose is prescribed to the patients at the beginning of the treatment as an introduction to the drug.

The 3 mg semaglutide tablet (often prescribed by the brand name of Rybelsus) is only used as an initial starting dose in order to help the body adapt to the drug for the first 30 days. This dose cannot be a maintenance dose for blood glucose control.